Dongkook Pharmaceutical plans to conduct a large-scale clinical trial in domestic, accepting the recommendation of the clinical trial re-evaluation of 'Insadol tablet'
Dongkook Pharmaceutical announced that they plan to conduct a large-scale clinical trial in domestic, accepting the recommendation of the clinical trial re-evaluation of 'Insadol tablet' from the Ministry of Food and Drug Safety.
Some media raised a question that Insadol was excluded from the Ph...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
